Identification and quantification of N -linked oligosaccharides released from glycoproteins: An inter-laboratory study

Glycobiology

Volumn 19, Issue 3, 2009, Pages 201-211

  Thobhani, Smita ^a   Yuen, Chun Ting ^b   Bailey, Marc J A ^a   Jones, Christopher ^b  

^a NATIONAL PHYSICAL LABORATORY   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Glycan analysis; Glycoproteins; IgG; N glycans; Sialylation

Indexed keywords

GLYCAN; GLYCOPROTEIN; IMMUNOGLOBULIN G; N ACETYLGLUCOSAMINE; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; OLIGOSACCHARIDE; OROSOMUCOID; PANCREATIC RIBONUCLEASE; RIBONUCLEASE;

ARTICLE; CARBOHYDRATE ANALYSIS; CHROMATOGRAPHY; CLUSTER ANALYSIS; CONTROLLED STUDY; FUCOSYLATION; GLYCOPROTEIN SYNTHESIS; GLYCOSYLATION; HUMAN; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIALYLATION; STRUCTURE ANALYSIS; UNITED KINGDOM;

ANIMALS; CATTLE; CHROMATOGRAPHY; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LABORATORY TECHNIQUES AND PROCEDURES; MASS SPECTROMETRY; OLIGOSACCHARIDES; POLYSACCHARIDES;

BOVINAE; TETRA;

EID: 58949101498     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn099     Document Type: Article

References (13)

1. Anonymous Specifications: Test procedures and acceptance criteria for biotechnological/biological products Q6B. Available at http://www.ich.org/cache/compo/363-272-1.html#Q6B.
2. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. 2007. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 25:21-50.
3. Feizi T, Stoll MS, Yuen CT, Chai WG, Lawson AM. 1994. Neoglycolipids - Probes of oligosaccharide structure, antigenicity, and function. Methods in Enzymology. 230: 484-519.
4. Ferrara C, Brunker P, Suter T, Moser S, Puntener U, Umana P. 2006. Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co-expression of heterologous beta 1,4-N acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. Biotechnol. Bioeng. 93:851-861.
5. Hara S, Takemori Y, Yamaguchi M, Nakamura M, Ohkura Y. 1987. Fluorometric high-performance liquid chromatography of N-acetyl- and N-glycolylneuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids. Anal Biochem. 164:138-145.
6. Jefferis R. 2005. Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 21:11-16.
7. Jefferis R. 2007. Antibody therapeutics: Isotype and glycoform selection. Expert Opin. Biol. Ther. 7:1401-1413.
8. Jefferis R, Lund J, Pound JD. 1998. IgG-Fc-mediated effector functions: Molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol. Rev. 163:59-76.
9. Raju TS, Briggs JB, Borge SM, Jones AJ. 2000. Species-specific variation in glycosylation of IgG: Evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology. 10:477-486.
10. Satoh M, Iida S, Shitara K. 2006. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opin Biol. Ther. 6:1161-1173.
11. Wada Y, Azadi P, Costello CE, Dell A, Dwek RA, Geyer H, Geyer R, Kakehi K, Karlsson NG, Kato K, et al. 2007. Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology. 17:411-422.
12. Youings A, Chang SC, Dwek RA, Scragg IG. 1996. Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem. J. 314:621-630.
13. Yuen CT, Gee CK, Jones C. 2002. High-performance liquid chromatographic profiling of fluorescent labelled N-glycans on glycoproteins. Biomed. Chromatogr. 16:247-254.